Filing Details

Accession Number:
0001179110-15-009330
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-08 16:48:54
Reporting Period:
2015-06-04
Filing Date:
2015-06-08
Accepted Time:
2015-06-08 16:48:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571523 Sanjay Malkani 51 Sawyer Road, Suite 200
Waltham MA 02453
Global Pres., Toxicology No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-04 10,000 $44.64 16,222 No 4 M Direct
Common Stock Acquisiton 2015-06-04 5,669 $19.20 21,891 No 4 M Direct
Common Stock Disposition 2015-06-04 15,669 $52.18 6,222 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-06-04 10,000 $0.00 10,000 $44.64
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-06-04 5,669 $0.00 5,669 $19.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2018-02-12 No 4 M Direct
44,331 2022-10-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 565 Indirect See Footnote
Footnotes
  1. Represents same day exercise and sale of stock options.
  2. Option vested in four equal annual installments on 2/12/09, 2/12/10 and 2/12/11, 2/12/12.
  3. Option will vest in four equal annual installments on 10/31/13, 10/31/14, 10/31/15 and 10/31/16.
  4. The derivative security does not have a price.
  5. The price reported is a weighted average price. These shares were sold in approximately 14 separate transactions at prices ranging from $52.00 to $52.265, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was affected.
  6. These securities are owned by the reporting person's spouse.
  7. The reporting person hereby disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16.